See more : Twelve Seas Investment Company II (TWLVU) Income Statement Analysis – Financial Results
Complete financial analysis of Bonesupport Holding AB (publ) (2B4.F) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Bonesupport Holding AB (publ), a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Vitasoy International Holdings Limited (0345.HK) Income Statement Analysis – Financial Results
- Motive Capital Corp. (MOTV-UN) Income Statement Analysis – Financial Results
- Türkiye Sise Ve Cam Fabrikalari A.S. (SISE.IS) Income Statement Analysis – Financial Results
- Sierra Lake Acquisition Corp. (SIERW) Income Statement Analysis – Financial Results
- SS&C Technologies Holdings, Inc. (0L1G.L) Income Statement Analysis – Financial Results
Bonesupport Holding AB (publ) (2B4.F)
About Bonesupport Holding AB (publ)
Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bioceramic bone graft substitutes for the treatment of bone voids in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable, moldable, and drillable synthetic bone void filler that includes hydroxyapatite, calcium sulfate, and the radio-contrast agent iohexol; CERAMENT G, a gentamicin injectable ceramic bone graft substitute; and CERAMENT V, a vancomycin injectable synthetic bone void filler. It also develops preclinical product candidates to promote bone regrowth focusing on trauma, revision arthroplasty, chronic osteomyelitis, revision artroplasty, and oncology, as well as bone and foot infections due to diabetes. The company was founded in 1999 and is headquartered in Lund, Sweden.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 591.08M | 328.82M | 212.89M | 180.86M | 155.46M | 96.62M | 129.30M | 104.60M | 61.76M | 40.96M |
| Cost of Revenue | 50.16M | 31.11M | 23.18M | 19.26M | 19.59M | 15.16M | 16.87M | 16.31M | 9.51M | 6.37M |
| Gross Profit | 540.92M | 297.71M | 189.70M | 161.60M | 135.88M | 81.47M | 112.43M | 88.29M | 52.25M | 34.59M |
| Gross Profit Ratio | 91.51% | 90.54% | 89.11% | 89.35% | 87.40% | 84.31% | 86.95% | 84.41% | 84.61% | 84.44% |
| Research & Development | 57.11M | 53.09M | 53.01M | 57.90M | 68.88M | 66.06M | 60.64M | 38.23M | 19.00M | 17.02M |
| General & Administrative | 90.31M | 73.31M | 44.12M | 45.49M | 43.28M | 58.35M | 57.48M | 60.67M | 31.70M | 23.51M |
| Selling & Marketing | 371.31M | 238.45M | 177.85M | 155.42M | 182.32M | 133.31M | 92.86M | 79.77M | 56.16M | 37.42M |
| SG&A | 461.62M | 311.75M | 221.97M | 200.91M | 225.60M | 191.66M | 150.34M | 140.44M | 87.86M | 60.93M |
| Other Expenses | 8.26M | 472.00K | -700.00K | -1.01M | -887.00K | -734.00K | -1.06M | -593.00K | -291.00K | -292.00K |
| Operating Expenses | 526.99M | 365.31M | 274.28M | 257.80M | 293.59M | 256.99M | 209.92M | 178.08M | 106.57M | 77.66M |
| Cost & Expenses | 577.15M | 396.42M | 297.46M | 277.05M | 313.18M | 272.14M | 226.79M | 194.39M | 116.07M | 84.03M |
| Interest Income | 4.94M | 811.00K | 1.17M | 5.00K | 98.00K | 46.00K | 3.00K | 4.00K | 1.00K | 1.00K |
| Interest Expense | 3.12M | 970.00K | 1.17M | 445.00K | 275.00K | 1.07M | 16.99M | 11.64M | 8.30M | 6.48M |
| Depreciation & Amortization | 10.07M | 9.38M | 8.28M | 7.64M | 7.13M | 829.00K | 382.00K | 214.00K | 1.29M | 1.25M |
| EBITDA | 28.94M | -54.34M | -72.39M | -90.91M | -150.87M | -172.97M | -101.55M | -92.24M | -49.71M | -43.35M |
| EBITDA Ratio | 4.90% | -16.53% | -34.17% | -50.12% | -96.66% | -178.22% | -84.84% | -91.68% | -80.71% | -105.92% |
| Operating Income | 13.93M | -67.61M | -84.57M | -96.19M | -157.72M | -174.40M | -99.29M | -88.75M | -53.91M | -39.30M |
| Operating Income Ratio | 2.36% | -20.56% | -39.73% | -53.19% | -101.45% | -180.50% | -76.79% | -84.84% | -87.29% | -95.95% |
| Total Other Income/Expenses | 1.82M | -159.00K | -1.17M | -440.00K | -177.00K | -465.00K | -28.58M | -20.82M | -5.51M | -11.77M |
| Income Before Tax | 15.75M | -64.69M | -81.84M | -99.00M | -158.28M | -174.87M | -127.86M | -109.57M | -59.42M | -51.07M |
| Income Before Tax Ratio | 2.66% | -19.67% | -38.44% | -54.74% | -101.81% | -180.98% | -98.89% | -104.75% | -96.21% | -124.69% |
| Income Tax Expense | -229.27M | 3.47M | 3.69M | 2.41M | 2.78M | 1.54M | 1.01M | 625.00K | 140.00K | -8.00K |
| Net Income | 245.02M | -68.17M | -85.53M | -101.41M | -161.06M | -176.41M | -128.87M | -110.19M | -59.56M | -51.07M |
| Net Income Ratio | 41.45% | -20.73% | -40.18% | -56.07% | -103.60% | -182.57% | -99.67% | -105.35% | -96.44% | -124.67% |
| EPS | 3.74 | -1.06 | -1.34 | -1.72 | -3.10 | -3.46 | -3.24 | -2.38 | -1.29 | -1.10 |
| EPS Diluted | 3.74 | -1.06 | -1.34 | -1.72 | -3.10 | -3.46 | -3.24 | -2.38 | -1.29 | -1.10 |
| Weighted Avg Shares Out | 65.51M | 64.45M | 64.00M | 59.08M | 51.89M | 50.97M | 39.83M | 46.25M | 46.25M | 46.25M |
| Weighted Avg Shares Out (Dil) | 65.59M | 64.45M | 64.00M | 59.08M | 51.89M | 50.97M | 39.83M | 46.25M | 46.25M | 46.25M |
Source: https://incomestatements.info
Category: Stock Reports